학술논문
Executive summary: Japanese pediatric guideline for the treatment and management of asthma (JPGL) 2020
Document Type
article
Author
Yuichi Adachi; Takumi Takizawa; Masaki Futamura; Takao Fujisawa; Shigemi Yoshihara; Committee members; Naoki Shimojo; Akira Iino; Mothiro Ebisawa; Hiroyuki Mochizuki; Yukihiro Ohya; Toshio Katsunuma; Makoto Kameda; Toshishige Inoue; Tatsuki Fukuie; External committee members; Takashi Iwanaga; Mariko Kuriyama; Haruo Kuroki; Mariko Sonobe; Masato Takase; Ikuyo Masuko; Collaborators; Fumiya Yamaide; Koichi Yoshida; Kenichi Nagakura; Kota Hirai; Yumiko Miyaji; Yasunori Ito; Hisako Yagi; Katsushi Miura; Satoshi Horino; Hironobu Fukuda; Yukinori Yoshida; Shinichi Takahashi; Osamu Natsume; Mizuho Nagao; Yoshiyuki Yamada; Members of systematic review team; Ikuo Okafuji; Kiwako Yamamoto-Hanada; Yoichi Nakajima; Yuya Tanaka; Shuichi Suzuki; Kotaro Sato; Hiroki Murai; Taro Miura; Yukiko Hiraguchi; Yuri Takaoka; Tetsuharu Manabe; Yu Kuwabara; Kenichi Akashi; Tomoki Nishikido; Mayumi Sugimoto; Mayu Maeda; Norio Kawamoto; Kyohei Takahashi; Akiko Yamaide; Takuya Wada; Hiroshi Kitazawa; Mayako Saito; Executive Adviser; Sankei Nishima
Source
Allergology International, Vol 71, Iss 4, Pp 472-480 (2022)
Subject
Language
English
ISSN
1323-8930
Abstract
This article covers the salient and updated themes of the Japanese Pediatric Guidelines for the Treatment and Management of Asthma (JPGL) 2020 published by the Japanese Society of Pediatric Allergy and Clinical Immunology. In the 2020 guidelines, five new clinical questions (CQs) have been added to address the 12 CQs regarding the treatment of childhood asthma. “Infant and preschool asthma” is diagnosed when young children (